Keyphrases
Confidence Interval
100%
Emergency Department
91%
Parkinson's Disease
72%
Spain
72%
Hazard Ratio
71%
D-dimer
67%
Neuroblastoma
63%
Randomized Clinical Trial
62%
Hepatocellular Carcinoma
59%
Cirrhosis
57%
Cerebrospinal Fluid
57%
Morbid Obesity
52%
COVID-19
48%
Overall Survival
48%
Odds Ratio
46%
Placebo
46%
Atrial Fibrillation
43%
Neonatal Foal
43%
Total Knee Arthroplasty
42%
Short-term Outcomes
40%
Sorafenib
40%
Adverse Events
40%
Kidney Transplant Recipients
39%
Clinical Features
39%
Acute Heart Failure
38%
Catalonia
38%
Barcelona
37%
Orphan Medicinal Product
36%
Functional Outcome
36%
Comorbidity
36%
Uveitic Macular Edema
35%
Risk Factors
35%
Macular Edema
34%
Best-corrected Visual Acuity
34%
Preterm Labor
33%
Obese Patients
33%
Kidney Transplantation
33%
Corneoscleral
32%
Clinical Outcomes
32%
Optical Coherence Tomography
31%
Neurosurgical Patients
31%
Cryopreserved
31%
Ultrastructural Study
31%
Dermatological Adverse Effects
31%
Leucine-rich Repeat Kinase 2 (LRRK2)
31%
Cryopreservation
31%
Bispectral Index
31%
Propensity Score Analysis
31%
Pulmonary Hypertension
31%
High Risk
31%
Medicine and Dentistry
Emergency Department
78%
Hazard Ratio
68%
Adverse Event
61%
Hepatocellular Carcinoma
58%
Overall Survival
55%
Infection
54%
Kidney Graft
53%
Placebo
50%
Neoplasm
50%
Biological Marker
49%
Diseases
49%
Apoplexy
46%
Prospective Study
46%
Premature Labor
45%
Optical Coherence Tomography
45%
Randomized Clinical Trial
44%
Atrial Fibrillation
43%
Odds Ratio
43%
Body Mass Index
42%
Sorafenib
42%
Total Knee Arthroplasty
42%
Macular Edema
41%
Obstructive Sleep Apnea
40%
Surgery
36%
Liver Cirrhosis
36%
Acute Decompensated Heart Failure
35%
Uveitis
34%
Macular Hole
33%
Congestive Heart Failure
33%
Kidney Transplantation
33%
COVID-19
32%
Human Immunodeficiency Virus
31%
Ganglioneuroblastoma
31%
Bispectral Index
31%
Dermatological Agent
31%
Neurosurgery
31%
Clinical Trial
31%
Graft Failure
30%
Retrospective Study
29%
Best Corrected Visual Acuity
29%
Liver Cancer
28%
Hip
27%
Hemodynamic
26%
Metastatic Carcinoma
25%
Kidney Function
24%
Anticoagulant Therapy
24%
Hepatitis C Virus
24%
Chronic Obstructive Pulmonary Disease
24%
Calcineurin Inhibitor
24%
Maintenance Therapy
23%